期刊文献+

昂丹司琼复合氟哌利多或地塞米松预防腹腔镜下胆囊切除术后患者恶心呕吐的疗效观察 被引量:9

原文传递
导出
摘要 目的腹腔镜胆囊切除术(LC)具有创口小,术后恢复快等优点,目前已在临床上广泛应用。但是其术后恶心呕吐(PONV)的发生率明显高于开腹的手术,在一定程度上增加了患者的痛苦和费用,对再次手术的害怕,反感。本文旨在比较各个药物在预防性用药中的疗效,寻找一个有效安全和经济实惠的镇吐配方。方法择期腹腔镜下行胆囊切除术后270例,ASAI或II级,随机分为6组(n=45例),采用常规的麻醉诱导和维持。术毕分别静脉注射等量生理盐水,为对照组(I组),昂丹司琼组4mg(用生理盐水稀释至5盯d,为II组),氟哌利多组1.25mg(用生理盐水稀释到5ml,为III组),地塞米松8mg(IV组),昂丹司琼4mg加氟哌利多1.25mg(V组),昂丹司琼4mg加地塞米松8mg(VI组),观察术后24h内恶心,干呕和呕吐的发生率,并用评分法(0~10分)评估其程度并记录评分及不良反应。结果与对照组相比,均能显著降低患者术后恶心,干呕和呕吐的发生率(P〈0.05)。结论昂丹司琼,氟哌利多或地塞米松均可减少腹腔镜胆囊切除术后恶心,干呕和呕吐的发生并降低其严重程度。小剂量昂丹司琼复合小剂量氟哌利多或小剂量地塞米松可以起到相互协同的作用,认为是一种很好的配伍。两种药物复合方式防治PONV的效果相同,均优于单独用药,各组均未发生一例椎体外系症状的副反应。据此可以认为静脉联合应用昂丹司琼和氟哌利多或地塞米松较适合于临床的使用和推广。
出处 《中国临床实用医学》 2010年第7期138-140,共3页 China Clinical Practical Medicine
  • 相关文献

参考文献19

  • 1孙增勤..实用麻醉手册[M],2001.
  • 2金珏,江维娜,于布为,郑民华.地塞米松复合恩丹西酮预防腹腔镜胆囊切除术后病人恶心呕吐的效果[J].中华麻醉学杂志,2005,25(12):943-944. 被引量:21
  • 3刘学胜,曾因明,张健.手术后恶心呕吐的研究进展[J].国外医学(麻醉学与复苏分册),2005,26(5):286-288. 被引量:44
  • 4权翔,叶铁虎.术后恶心呕吐的风险评估及防治方法[J].国际麻醉学与复苏杂志,2007,28(3):253-256. 被引量:33
  • 5周德华.实用麻醉科药物手册.人民军医出版社,2002:186-187. 被引量:1
  • 6Tramer MR, Reynolds JM, Moore RA, et al. Efficacy, doseresponse, and safety of ondamsetron in prevention of postoperative maused amd vomiting:aquantitative systemic review of randomized. Place clo-controlled trials. Anesthesiology, 1997,87 : 1277-1289. 被引量:1
  • 7Tang T, Wang B, White PF, et al. The effect of timing of ondamsetron administration on its efficacy,cost-effectiveness, and cost-benefit as a prophylactic antiemetie in the ambulatory setting. Analg, 1998,86:274-282. 被引量:1
  • 8Henzil, Sonderegger J, Trainer MR. Efficacy, dose-reponse, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anesth,2000,97:537-551. 被引量:1
  • 9Hill RP, ludarsky DA, PhiUips-Bute B, et al. Cost-effectiveness of Prophylactic antiemetic therapy with ondansetron, droperido I or Placebo. Anesthesiology ,2000,92:958-967. 被引量:1
  • 10Chan MT, Choikc, Gint, Chui PT, Short TG, Yuen PM, Poon AH, APfeI cc, Gan TJ. The additive interactions between ondansetron and droperidol for for preventing postoperative nausea and vomiting. Analg 2006,103:1155-1162. 被引量:1

二级参考文献81

  • 1Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology, 1992, 77:162-184. 被引量:1
  • 2Apfcl CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology, 1999, 91:693-700. 被引量:1
  • 3Gan TJ. Risk factors for postoperative nausea and vomiting. Anesth Analg, 2006, 102:1884-1898. 被引量:1
  • 4lerman J. Surgical and patient factors involved in postoperative nausea and vomiting. Br J Anaesth, 1992, 69:24-32. 被引量:1
  • 5Apfel CC, Kranke P, Eberhart LH. Comparison of surgical site and patients history with a simplified risk score for the prediction of postoperative nausea and vomiting. Anaesthesia, 2004, 59:1078-1082. 被引量:1
  • 6Kranke P, Apefel CC, Papenfuss T, et al. An increased body mass index is no risk factor for postoperative nausea and vomiting. Acta Anaesthesiol Scand, 2001, 45 : 160-166. 被引量:1
  • 7Stadler M, Bardiau F, Seidel L, et al. Difference in risk factors for postoperative nausea and vomiting. Anesthesiology, 2003, 98 : 46-52. 被引量:1
  • 8Eberhart LH, Geldner G, Kranke P, et al. The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients. Anesth Analg, 2004, 99 : 1630-1637. 被引量:1
  • 9Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med, 2004, 350:2441-2451. 被引量:1
  • 10Habib AS, El Moalem HE, Gan TJ. The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. Can J Anaesth, 2004, 51:311-319. 被引量:1

共引文献171

同被引文献53

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部